NO865302L - Fremgangsmaate for fremstilling av immunoforsterkere og beslektede forbindelser. - Google Patents
Fremgangsmaate for fremstilling av immunoforsterkere og beslektede forbindelser.Info
- Publication number
- NO865302L NO865302L NO865302A NO865302A NO865302L NO 865302 L NO865302 L NO 865302L NO 865302 A NO865302 A NO 865302A NO 865302 A NO865302 A NO 865302A NO 865302 L NO865302 L NO 865302L
- Authority
- NO
- Norway
- Prior art keywords
- immuno
- amplifiers
- procedure
- manufacture
- related relations
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/464838—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
- C07K4/12—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/813,632 US4699898A (en) | 1985-12-26 | 1985-12-26 | Tripeptides affecting immune response |
US90268386A | 1986-09-02 | 1986-09-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO865302D0 NO865302D0 (no) | 1986-12-23 |
NO865302L true NO865302L (no) | 1987-06-29 |
Family
ID=27123762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO865302A NO865302L (no) | 1985-12-26 | 1986-12-23 | Fremgangsmaate for fremstilling av immunoforsterkere og beslektede forbindelser. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0230052B1 (ja) |
JP (1) | JP2502553B2 (ja) |
AU (1) | AU619441B2 (ja) |
CA (1) | CA1286989C (ja) |
DE (1) | DE3689767T2 (ja) |
DK (1) | DK612786A (ja) |
FI (1) | FI865267A (ja) |
IL (1) | IL81072A0 (ja) |
NO (1) | NO865302L (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0238851B1 (en) * | 1986-02-19 | 1992-12-09 | Imreg, Inc. | A method and means of assaying an immune system |
US4880779A (en) * | 1987-07-31 | 1989-11-14 | Research Corporation Technologies, Inc. | Method of prevention or treatment of AIDS by inhibition of human immunodeficiency virus |
CA1340588C (en) * | 1988-06-13 | 1999-06-08 | Balraj Krishan Handa | Amino acid derivatives |
GB8927913D0 (en) * | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Amino acid derivatives |
DE4303530C2 (de) * | 1993-02-06 | 1997-04-03 | Milan C Dr Med Pesic | Pharmazeutische Verwendung eines Enkephalins |
RU2107692C1 (ru) | 1995-06-07 | 1998-03-27 | Дейгин Владислав Исакович | Пептид и способ его получения |
RU2107691C1 (ru) | 1995-03-02 | 1998-03-27 | Дейгин Владислав Исакович | Пептид и способ его получения |
US7632818B2 (en) * | 2003-03-20 | 2009-12-15 | Gottlieb Marise S | Method for treating conditions associated with the Metabolic Syndrome (Syndrome X) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO156516C (no) * | 1980-05-14 | 1987-10-07 | A Arthur Gottlieb | Fremgangsmaate for fremstilling av modulatorer for immunsystemet. |
US4468379A (en) * | 1982-05-06 | 1984-08-28 | Endeavor Corp. | Leukocyte extracts for affecting the immune system |
DK134784A (da) * | 1983-03-07 | 1984-09-08 | Lilly Co Eli | Farmakologisk virksomme tripeptid-derivater og fremgangsmaade til fremstilling deraf |
US4599325A (en) * | 1984-02-16 | 1986-07-08 | G. D. Searle & Co. | Substituted tyrosyl alanine dipeptide amides |
US4616079A (en) | 1984-08-24 | 1986-10-07 | Imreg, Inc. | Immunoamplifiers and processes for the extraction thereof |
US4710380A (en) | 1986-04-04 | 1987-12-01 | Imreg, Inc. | Treatment of autoimmune disorders with immunoamplifiers |
-
1986
- 1986-12-15 CA CA000525328A patent/CA1286989C/en not_active Expired - Lifetime
- 1986-12-18 DK DK612786A patent/DK612786A/da not_active Application Discontinuation
- 1986-12-22 IL IL81072A patent/IL81072A0/xx unknown
- 1986-12-22 FI FI865267A patent/FI865267A/fi not_active Application Discontinuation
- 1986-12-23 NO NO865302A patent/NO865302L/no unknown
- 1986-12-24 AU AU66970/86A patent/AU619441B2/en not_active Ceased
- 1986-12-25 JP JP61316026A patent/JP2502553B2/ja not_active Expired - Lifetime
- 1986-12-29 EP EP86118104A patent/EP0230052B1/en not_active Expired - Lifetime
- 1986-12-29 DE DE3689767T patent/DE3689767T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
FI865267A (fi) | 1987-06-27 |
DE3689767T2 (de) | 1994-08-25 |
DK612786A (da) | 1987-06-27 |
NO865302D0 (no) | 1986-12-23 |
IL81072A0 (en) | 1987-03-31 |
AU619441B2 (en) | 1992-01-30 |
AU6697086A (en) | 1987-07-02 |
FI865267A0 (fi) | 1986-12-22 |
EP0230052B1 (en) | 1994-04-06 |
DK612786D0 (da) | 1986-12-18 |
DE3689767D1 (de) | 1994-05-11 |
CA1286989C (en) | 1991-07-30 |
EP0230052A2 (en) | 1987-07-29 |
JPS62228023A (ja) | 1987-10-06 |
JP2502553B2 (ja) | 1996-05-29 |
EP0230052A3 (en) | 1989-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO167138C (no) | Keramisk formdel og anvendelse av denne. | |
NO882762D0 (no) | Fremgangsmaate for fremstilling av antihypertensive og antiarytmiske forbindelser. | |
NO890045D0 (no) | Baatskrog og fremgangsmaate for fremstilling og belegging derav. | |
DK461387A (da) | Fremgangsmaade til fremstilling af optegnelsesark og anvendelse deraf til fremstilling af flexotrykforme. | |
NO853120L (no) | Isfjell og fremgangsmaate for fremstilling av samme. | |
NO862853D0 (no) | Fremgangsmaate for fremstilling av askefattig og elektrisk ledende sot. | |
NO156383C (no) | Vernegitter e.l. og framgangsmte for tilvirking av dette. | |
NO882940D0 (no) | Fremgangsmaate for fremstilling av castanosperminestere og glycosider. | |
NO865302L (no) | Fremgangsmaate for fremstilling av immunoforsterkere og beslektede forbindelser. | |
NO863378L (no) | Fremgangsmaate og anordning for fremstilling av varmeisolerte roerledninger. | |
NO851452L (no) | Fremgangsmaate og cellelinje for fremstilling av plasminogene aktivatorer. | |
NO881713L (no) | Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere. | |
NO860507L (no) | Fremgangsmaate for fremstilling av arylglycidyletere og 3-substituerte 1-alkylamino-2-propanoler. | |
NO863113D0 (no) | Fremgangsmaate for fremstilling av heterocyclocarbonyl- og acetyl-thiazoloner. | |
NO891630D0 (no) | Fremgangsmaate og anordning for fremstilling av diafragmer. | |
NO880592D0 (no) | Herdbare harpikser, fremgangsmaate for fremstilling av disse og anvendelse av disse. | |
NO882336D0 (no) | Fremgangsmaate for fremstilling av 5-metoksyalkylammoniun-tetrahydrofuraner og tetrahydrotiofener. | |
NO862823L (no) | Fremgangsmaate for fremstilling av lenser og liknende. | |
DE3880552D1 (de) | Polyaether-polyamid-blockcopolymer und polyaether-praepolymer. | |
NO163885C (no) | Fremgangsmaate og innretning for korrugering av metallroer. | |
NO165956C (no) | Fremgangsmaate for fremstilling av hydrokarboner og oksygenerte hydrokarboner. | |
NO164530C (no) | Fremgangsmaate for fremstilling av blandingssprengstoffer av typen hexotonal og octonal. | |
NO861324L (no) | Anordning og fremgangsmaate for fremstilling av polymeriske legemer. | |
NO874487D0 (no) | Framgangsmaate for tilvirkning av poelser og liknende produkter. | |
NO912279L (no) | Fremgangsmaate for fremstilling og anvendelse av eksplosjonssikre 1-dimetylamino-3-dimetylimino-2-arylprop-1-en-salter. |